Jantibody - H-CYTE
Alternative Names: scFvMTBHsp70 fusion proteinLatest Information Update: 10 Oct 2022
At a glance
- Originator Harvard Medical School; Vaccine and Immunotherapy Center
- Developer H-CYTE; Harvard Medical School; Vaccine and Immunotherapy Center
- Class Antineoplastics; Immunoglobulin Fv fragments; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Mesothelioma; Ovarian cancer